European Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher in Monday Trading
Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Silence Therapeutics (SLN) and Exscientia Plc (EXAI)
European Equities Traded in the US as American Depositary Receipts Trend Lower Friday; Set to End Week Down 4%
European Equities Traded in the US as American Depositary Receipts Fall in Wednesday Trading
Silence Therapeutics (SLN) Receives a Buy From Morgan Stanley
Institutional Investors Are Silence Therapeutics Plc's (NASDAQ:SLN) Biggest Bettors and Were Rewarded After Last Week's US$76m Market Cap Gain
We're Hopeful That Silence Therapeutics (NASDAQ:SLN) Will Use Its Cash Wisely
European Equities Traded in the US as American Depositary Receipts Climb Higher in Friday Trading
Silence Therapeutics (SLN) Moves 5.8% Higher: Will This Strength Last?
BMO Sees BMRN, LEGN, SLN as Attractive M&A Targets
European Equities Traded in the US as American Depositary Receipts Flat in Monday Trading
Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Maintains Target Price $49
Silence Therapeutics (SLN) Gets a Buy From Morgan Stanley
European Equities Traded in the US as American Depositary Receipts Trend Lower in Tuesday Trading
Chardan Capital Maintains Silence Therapeutics(SLN.US) With Buy Rating, Raises Target Price to $55
Morgan Stanley Maintains Silence Therapeutics(SLN.US) With Buy Rating, Raises Target Price to $49
European Equities Traded in the US as American Depositary Receipts Nudge Higher in Friday Trading
A Quick Look at Today's Ratings for Silence Therapeutics(SLN.US), With a Forecast Between $49 to $75
Silence Therapeutics Is Maintained at Buy by Chardan Capital
Express News | Chardan Capital Maintains Buy on Silence Therapeutics, Raises Price Target to $55
No Data